FDA-Cleared HSV-1/2 Assay
FDA has cleared the IMDx HSV-1/2 assay for Abbott m2000, a test that detects and differentiates herpes simplex virus type 1 and type 2 from male and female skin lesions from anogenital or oral sites.
Read MorePosted by Jenny Lower | Jun 23, 2014 | Infectious Diseases, Sexually Transmitted Diseases |
FDA has cleared the IMDx HSV-1/2 assay for Abbott m2000, a test that detects and differentiates herpes simplex virus type 1 and type 2 from male and female skin lesions from anogenital or oral sites.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Expert guidelines for initially confirming HIV infection are changing this year, moving away from dependence upon Western blot and emphasizing more practical, rapid tests.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Today’s STD and HIV testing devices strive to deliver rapid results in a variety of clinical settings. Some offer advances never seen before.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Screening for sexually transmitted diseases is bringing a hidden epidemic into the spotlight. It’s also critical to keeping tabs on antimicrobial resistance.
Read MorePosted by Jenny Lower | Jun 9, 2014 | Rapid Assays |
With quick test results come public health benefits and better treatment, but for some rapid diagnostic tests, accuracy remains elusive.
Read More